2025 Year in Review: Looking Ahead to Psychedelics in 2026 (Video)
Watch the second video in our 2025 Year in Review series. This narrated slide deck, presented by Psychedelic Alpha Founder & Editor Josh Hardman, looks ahead to 2026. In this video, Hardman considers potential FDA approvals, Phase 3 readouts, alternative pathways to access, and more...
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks
Already a member?
Sign In